US 12,220,300 B2
Partially transparent wound dressing
Thomas A. Edwards, Hampshire (GB); Christopher B. Locke, Bournemouth (GB); Timothy M. Robinson, Wimbourne (GB); and Justin A. Long, Bournemouth (GB)
Assigned to Solventum Intellectual Properties Company, Maplewood, MN (US)
Appl. No. 17/424,009
Filed by Solventum Intellectual Properties Company, Maplewood, MN (US)
PCT Filed Jan. 27, 2020, PCT No. PCT/US2020/015188
§ 371(c)(1), (2) Date Jul. 19, 2021,
PCT Pub. No. WO2020/159859, PCT Pub. Date Aug. 6, 2020.
Claims priority of provisional application 62/799,998, filed on Feb. 1, 2019.
Prior Publication US 2022/0079815 A1, Mar. 17, 2022
Int. Cl. A61F 13/0203 (2024.01); A61F 13/00 (2024.01); A61F 13/02 (2024.01); A61F 13/0206 (2024.01)
CPC A61F 13/0223 (2013.01) [A61F 13/0206 (2013.01); A61F 13/022 (2013.01); A61F 13/0276 (2013.01); A61F 2013/00182 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A dressing comprising:
a fluid management core having a first side and a second, wound-facing side, the fluid management core comprising an absorbent material and a plurality of windows, the second side comprising a fluid communication port in fluid communication with the absorbent material, wherein the fluid management core further comprises:
a first fluid management layer comprising a first plurality of extensions, and
a second fluid management layer comprising a second plurality of extensions, wherein the first plurality of extensions are aligned with and coupled to the second plurality of extensions;
a barrier layer coupled to the first side of the fluid management core; and
a patient interface layer coupled to the second side of the fluid management core, wherein the patient interface layer includes an opening, and wherein the opening is configured to receive fluid from a wound.